A Plus Biotechnology Co (TPE:6918) Days Inventory: 429.75 (As of Dec. 2025) — 13% Below Median


TPE:6918 A Plus Biotechnology Co Ltd TPE:6918
71 GF Score
Price NT$74.20
GF Value NT$87.17
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is A Plus Biotechnology Co Days Inventory?

A Plus Biotechnology Co TPE:6918 -0.13% 71 Days Inventory is 429.75 as of Dec. 2025, which is 13% below its 10-year median of 493.30. GuruFocus rates TPE:6918 with a GF Score™ of 71/100 and a GF Value™ of NT$87.17 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 784 Medical Devices & Instruments companies, A Plus Biotechnology Co ranks worse than 88.39% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). A Plus Biotechnology Co's Average Total Inventories for the three months ended in Dec. 2025 was NT$343.8 Mil. A Plus Biotechnology Co's Cost of Goods Sold for the three months ended in Dec. 2025 was NT$73.0 Mil. Hence, A Plus Biotechnology Co's Days Inventory for the three months ended in Dec. 2025 was 429.75.

The historical rank and industry rank for A Plus Biotechnology Co's Days Inventory or its related term are showing as below:

TPE:6918' s Days Inventory Range Over the Past 10 Years
Min: 439.99   Med: 493.3   Max: 944.28
Current: 439.99

During the past 7 years, A Plus Biotechnology Co's highest Days Inventory was 944.28. The lowest was 439.99. And the median was 493.30.

TPE:6918's Days Inventory is ranked worse than
88.39% of 784 companies
in the Medical Devices & Instruments industry
Industry Median: 179.6 vs TPE:6918: 439.99

A Plus Biotechnology Co's Days Inventory increased from Dec. 2024 (417.68) to Dec. 2025 (429.75). It might indicate that A Plus Biotechnology Co's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. A Plus Biotechnology Co's Inventory Turnover for the three months ended in Dec. 2025 was 0.21.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. A Plus Biotechnology Co's Inventory-to-Revenue for the three months ended in Dec. 2025 was 1.60.


A Plus Biotechnology Co  (TPE:6918) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

A Plus Biotechnology Co's Inventory Turnover for the three months ended in Dec. 2025 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

A Plus Biotechnology Co's Inventory to Revenue for the three months ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


A Plus Biotechnology Co Days Inventory Related Terms


A Plus Biotechnology Co Days Inventory Historical Data

* Premium members only.

The historical data trend for A Plus Biotechnology Co's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A Plus Biotechnology Co Days Inventory Chart

A Plus Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial 539.48 446.16 493.30 443.56 446.09

A Plus Biotechnology Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 417.68 486.51 409.59 437.25 429.75

TPE:6918 vs ABT, SYK, MDT: Days Inventory Comparison

For the Medical Devices subindustry, A Plus Biotechnology Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


A Plus Biotechnology Co Days Inventory vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, A Plus Biotechnology Co's Days Inventory distribution charts can be found below:

* The bar in red indicates where A Plus Biotechnology Co's Days Inventory falls into.


TPE:6918
71GF Score
A Plus Biotechnology Co Ltd TPE:6918
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

A Plus Biotechnology Co Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

A Plus Biotechnology Co's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (286.939 + 354.536) / 2 ) / 262.433*365
=320.7375 / 262.433*365
=446.09

A Plus Biotechnology Co's Days Inventory for the quarter that ended in Dec. 2025 is calculated as:

Days Inventory (Q: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Sep. 2025 ) + Total Inventories (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (333.068 + 354.536) / 2 ) / 73.001*365 / 4
=343.802 / 73.001*365 / 4
=429.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 429.75 mean?
A Plus Biotechnology Co (TPE:6918) has a Days Inventory of 429.75 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on A Plus Biotechnology Co and its competitors. This is 13% below median its historical median of 493.30. Over the past decade, A Plus Biotechnology Co's Days Inventory has ranged from 439.99 to 944.28. According to the industry distribution chart, A Plus Biotechnology Co ranks #693 out of 784 companies in the Medical Devices & Instruments industry, placing it in the top 88.4%.
Is A Plus Biotechnology Co's Days Inventory too high?
A Plus Biotechnology Co's current Days Inventory of 429.75 is 13% below median its 10-year median of 493.30. Over the past 10 years, this metric has ranged from a low of 439.99 to a high of 944.28. The Medical Devices & Instruments industry median Days Inventory is 179.60. A Plus Biotechnology Co's value of 429.75 is 139.3% above this industry median. Based on the distribution chart, A Plus Biotechnology Co ranks #693 out of 784 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, A Plus Biotechnology Co has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does A Plus Biotechnology Co's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, A Plus Biotechnology Co ranks #693 out of 784 companies for Days Inventory. This places A Plus Biotechnology Co in the lower half of its industry. The industry median Days Inventory is 179.60. A Plus Biotechnology Co's value of 429.75 is 139.3% above this benchmark. Historically, A Plus Biotechnology Co's own Days Inventory has ranged from 439.99 to 944.28 over the past decade. While the company's 10-year median is 493.30 vs. the industry median of 179.60, A Plus Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 784 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. A Plus Biotechnology Co's current Days Inventory of 429.75 is 139.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on A Plus Biotechnology Co and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. A Plus Biotechnology Co's current Days Inventory is 429.75, which is 13% below median its own 10-year median of 493.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is A Plus Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, A Plus Biotechnology Co (TPE:6918) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$87.17, compared to a current price of NT$74.20 — trading 14.9% below its estimated fair value. The current Days Inventory is 429.75, which is 13% below median its 10-year median of 493.30 and 139.3% above the Medical Devices & Instruments industry median of 179.60. A Plus Biotechnology Co's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For A Plus Biotechnology Co (TPE:6918), the current Days Inventory is 429.75 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is A Plus Biotechnology Co (TPE:6918) Overvalued in 2026?

Based on GuruFocus' analysis, A Plus Biotechnology Co stock appears to be undervalued. The current stock price of NT$74.20 is trading 14.9% below its estimated GF Value™ of NT$87.17. GuruFocus considers A Plus Biotechnology Co to be Modestly Undervalued.

Key valuation signals for TPE:6918:

  • Days Inventory: 429.75 (13% below median its 10-year median of 493.30)
  • GF Value™: NT$87.17 vs. price of NT$74.20 (14.9% below fair value)
  • GF Score™: 71/100 with 3 warning signs
  • Industry Position: 139.3% above the Medical Devices & Instruments median (#693 of 784)

No single metric tells the full story. See the TPE:6918 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


A Plus Biotechnology Co Business Description

Address No. 21, Qiaohe Road, 3rd Floor, Zhonghe District, New Taipei City, TWN
A Plus Biotechnology Co Ltd provides orthopedic implants and engages in the manufacturing and wholesale of medical devices such as bone material. The company's products include Chest, Shoulder, Spine, Elbow, Wrist & Hand, Pelvic & Hip, Knee, Foot & Ankle, Osteotomy, Pediatric & ESF, and Biologics. The company currently has operating segments in Taiwan and China, with the majority of revenue coming from Taiwan.
71GF Score

Get the complete analysis for TPE:6918

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$74.20
Price
NT$87.17
GF Value